Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sendi Montanic"'
Autor:
Alexandra Bogožalec Košir, Tjaša Lukan, Mateja Kukovec, Sendi Montanič, Vivijana Snoj, Vladka Čurin Šerbec, Uroš Rajčević
Publikováno v:
Zdravniški Vestnik, Vol 86, Iss 5-6 (2017)
Background: Monoclonal antibodies (mAbs) are an important tool in diagnostics and research, especially when we are dealing with a protein marker of unknown primary structure as in the case of bilitranslocase (BTL). BTL is also expressed on kidney cel
Externí odkaz:
https://doaj.org/article/ad98f280e7704d06b4bfb00fc24c6503
Publikováno v:
Zdravniški Vestnik, Vol 81, Iss SUPL II (2012)
Background: HSC transplantation outcome is associated with the level of HLA matching between donor and recipient. A search for HSC donor starts in the patient’s family. In the absence of related donor, HLA matched unrelated donors are searched in r
Externí odkaz:
https://doaj.org/article/b3ba5da69d8c46eaab31f156c108113b
Autor:
Annette Fink, Dianne De Santis, Manuela Testi, Marcel G.J. Tilanus, Blanka Vidan-Jeras, Thuong Hien Tran, Gottfried Fischer, Mathijs Groeneweg, Ingrid Fae, Marco Andreani, Ben M. Matern, Christina E.M. Voorter, R. Whidborne, Sendi Montanic
Publikováno v:
Human Immunology. 79(11):763-772
The gold standard for typing at the allele level of the highly polymorphic Human Leucocyte Antigen (HLA) gene system is sequence based typing. Since sequencing strategies have mainly focused on identification of the peptide binding groove, full-lengt
Publikováno v:
HLA, 91(3), 212-212. Wiley
HLA-C*05:156 allele differs from C*05:01:01:02 by a nucleotide change in exon 2 at codon 9.
Publikováno v:
Human Immunology. 78:146
Aim Excluding null alleles and resolving ambiguities within G groups are mandatory in the laboratories serving unrelated HSCT programs. Since routine sequencing strategies have mainly focused on exons 2 and 3, for more than 90% of the HLA alleles val
Autor:
Sabina Kunilo Jamnik, Blanka Vidan-Jeras, Orjeta Bonaca, Natalija Ambrož, Miha Arnol, Natalija Pišec, Dolores Hrušovar, Sendi Montanic, Katja Rotar, Eva Plešec
Publikováno v:
Human Immunology. 78:214
Aim Development of de novo donor-specific HLA antibodies (DSA) after kidney and heart transplantation limits the long term success of this therapy and may lead to new transplantation. Luminex-supported single antigen bead assay (SAB) represents a maj